Although a link between intrinsic sensitivity to EGFR TKIs and tumor E-cadherin expression has been proposed, the direct role of E-cadherin loss in acquisition of resistance to this class of drugs is not universally agreed upon. The gene discussed is EGFR; the disease is neoplasm.